Myristoylation negative msbB-mutants of probiotic E. coli Nissle 1917 retain tumor specific colonization properties but show less side effects in immunocompetent mice

References

• Cheong I, Huang X, Bettegowda C, Diaz LA Jr, Kinzler KW, Zhou S, et al. A bacterial protein enhances the release and efficacy of liposomal cancer drugs. Science 2006; 314:1308 - 1311
   PubMed Web of Science ®Google Scholar
• Fu W, Chu L, Han X, Liu X, Ren D. Synergistic antitumoral effects of human telomerase reverse transcriptase-mediated dual-apoptosis-related gene vector delivered by orally attenuated Salmonella enterica Serovar typhimurium in murine tumor models. J Gene Med 2008; 10:690 - 701
   PubMed Web of Science ®Google Scholar
• Fu W, Lan H, Li S, Han X, Gao T, Ren D. Synergistic antitumor efficacy of suicide/ePNP gene and 6-methylpurine 2′-deoxyriboside via Salmonella against murine tumors. Cancer Gene Ther 2008; 15:474 - 484
   PubMed Web of Science ®Google Scholar
• Friedlos F, Lehouritis P, Ogilvie L, Hedley D, Davies L, Bermudes D, et al. Attenuated Salmonella targets prodrug activating enzyme carboxypeptidase G2 to mouse melanoma and human breast and colon carcinomas for effective suicide gene therapy. Clin Cancer Res 2008; 14:4259 - 4266
   PubMed Web of Science ®Google Scholar
• al-Ramadi BK, Fernandez-Cabezudo MJ, El-Hasasna H, Al-Salam S, Bashir G, Chouaib S. Potent anti-tumor activity of systemically-administered IL2-expressing Salmonella correlates with decreased angiogenesis and enhanced tumor apoptosis. Clin Immunol 2009; 130:89 - 97
   PubMed Web of Science ®Google Scholar
• Ryan RM, Green J, Williams PJ, Tazzyman S, Hunt S, Harmey JH, et al. Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors. Gene Ther 2009; 16:329 - 339
   PubMed Web of Science ®Google Scholar
• Hayashi K, Zhao M, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, et al. Cancer metastasis directly eradicated by targeted therapy with a modified Salmonella typhimurium. J Cell Biochem 2009; 106:992 - 998
   PubMed Web of Science ®Google Scholar
• Loeffler M, Le'Negrate G, Krajewska M, Reed JC. Salmonella typhimurium engineered to produce CCL21 inhibit tumor growth. Cancer Immunol Immunother 2009; 58:769 - 775
   PubMed Web of Science ®Google Scholar
• Loeffler M, Le'Negrate G, Krajewska M, Reed JC. IL-18-producing Salmonella inhibit tumor growth. Cancer Gene Ther 2008; 15:787 - 794
   PubMed Web of Science ®Google Scholar
• Loeffler M, Le'Negrate G, Krajewska M, Reed JC. Inhibition of tumor growth using salmonella expressing Fas ligand. J Natl Cancer Inst 2008; 100:1113 - 1116
   PubMed Web of Science ®Google Scholar
• Mengesha A, Dubois L, Chiu RK, Paesmans K, Wouters BG, Lambin P, et al. Potential and limitations of bacterial-mediated cancer therapy. Front Biosci 2007; 12:3880 - 3891
   PubMed Web of Science ®Google Scholar
• Loeffler M, Le'Negrate G, Krajewska M, Reed JC. Attenuated Salmonella engineered to produce human cytokine LIGHT inhibit tumor growth. Proc Natl Acad Sci USA 2007; 104:12879 - 12883
   PubMed Web of Science ®Google Scholar
• Zhang L, Gao L, Zhao L, Guo B, Ji K, Tian Y, et al. Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs. Cancer Res 2007; 67:5859 - 5864
   PubMed Web of Science ®Google Scholar
• Royo JL, Becker PD, Camacho EM, Cebolla A, Link C, Santero E, et al. In vivo gene regulation in Salmonella spp. by a salicylate-dependent control circuit. Nat Methods 2007; 4:937 - 942
   PubMed Web of Science ®Google Scholar
• Wei MQ, Ellem KA, Dunn P, West MJ, Bai CX, Vogelstein B. Facultative or obligate anaerobic bacteria have the potential for multimodality therapy of solid tumours. Eur J Cancer 2007; 43:490 - 496
   PubMed Web of Science ®Google Scholar
• Yu YA, Shabahang S, Timiryasova TM, Zhang Q, Beltz R, Gentschev I, et al. Visualization of tumors and metastases in live animals with bacteria and vaccinia virus encoding light-emitting proteins. Nat Biotechnol 2004; 22:313 - 320
   PubMed Web of Science ®Google Scholar
• Stritzker J, Weibel S, Hill PJ, Oelschlaeger TA, Goebel W, Szalay AA. Tumor-specific colonization, tissue distribution, and gene induction by probiotic Escherichia coli Nissle 1917 in live mice. Int J Med Microbiol 2007; 297:151 - 162
   PubMed Web of Science ®Google Scholar
• Pawelek JM, Low KB, Bermudes D. Bacteria as tumour-targeting vectors. Lancet Oncol 2003; 4:548 - 556
   PubMed Web of Science ®Google Scholar
• King I, Itterson M, Bermudes D. Tmor-targeted Salmonella typhimurium overexpressing cytosine deaminase: a novel, tumor-selective therapy. Methods Mol Biol 2009; 542:649 - 659
   PubMedGoogle Scholar
• Cunningham C, Nemunaitis J. A phase I trial of genetically modified Salmonella typhimurium expressing cytosine deaminase (TAPET-CD, VNP20029) administered by intratumoral injection in combination with 5-fluorocytosine for patients with advanced or metastatic cancer. Protocol no: CL-017. Version: April 9, 2001. Hum Gene Ther 2001; 12:1594 - 1596
   PubMedGoogle Scholar
• Toso JF, Gill VJ, Hwu P, Marincola FM, Restifo NP, Schwartzentruber DJ, et al. Phase I study of the intravenous administration of attenuated Salmonella typhimurium to patients with metastatic melanoma. J Clin Oncol 2002; 20:142 - 152
   PubMed Web of Science ®Google Scholar
• Aderem A, Ulevitch RJ. Toll-like receptors in the induction of the innate immune response. Nature 2000; 406:782 - 787
   PubMed Web of Science ®Google Scholar
• Raetz CR, Whitfield C. Lipopolysaccharide endotoxins. Annu Rev Biochem 2002; 71:635 - 700
   PubMed Web of Science ®Google Scholar
• Kotani S, Takada H, Tsujimoto M, Ogawa T, Takahashi I, Ikeda T, et al. Synthetic lipid A with endotoxic and related biological activities comparable to those of a natural lipid A from an Escherichia coli re-mutant. Infect Immun 1985; 49:225 - 237
   PubMed Web of Science ®Google Scholar
• Golenbock DT, Hampton RY, Qureshi N, Takayama K, Raetz CR. Lipid A-like molecules that antagonize the effects of endotoxins on human monocytes. J Biol Chem 1991; 266:19490 - 19498
   PubMed Web of Science ®Google Scholar
• Loppnow H, Brade H, Durrbaum I, Dinarello CA, Kusumoto S, Rietschel ET, et al. IL-1 induction-capacity of defined lipopolysaccharide partial structures. J Immunol 1989; 142:3229 - 3238
   PubMed Web of Science ®Google Scholar
• Rietschel ET, Kirikae T, Schade FU, Mamat U, Schmidt G, Loppnow H, et al. Bacterial endotoxin: molecular relationships of structure to activity and function. FASEB J 1994; 8:217 - 225
   PubMed Web of Science ®Google Scholar
• Low KB, Ittensohn M, Le T, Platt J, Sodi S, Amoss M, et al. Lipid A mutant Salmonella with suppressed virulence and TNFα induction retain tumor-targeting in vivo. Nat Biotechnol 1999; 17:37 - 41
   PubMed Web of Science ®Google Scholar
• Clairmont C, Lee KC, Pike J, Ittensohn M, Low KB, Pawelek J, et al. Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium. J Infect Dis 2000; 181:1996 - 2002
   PubMed Web of Science ®Google Scholar
• Blum G, Marre R, Hacker J. Properties of Escherichia coli strains of serotype O6. Infection 1995; 23:234 - 236
   PubMed Web of Science ®Google Scholar
• Karow M, Georgopoulos C. Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. J Bacteriol 1992; 174:702 - 710
   PubMed Web of Science ®Google Scholar
• Somerville JE Jr, Cassiano L, Bainbridge B, Cunningham MD, Darveau RP. A novel Escherichia coli lipid A mutant that produces an anti-inflammatory lipopolysaccharide. J Clin Invest 1996; 97:359 - 365
   PubMed Web of Science ®Google Scholar
• Grozdanov L, Zahringer U, Blum-Oehler G, Brade L, Henne A, Knirel YA, et al. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J Bacteriol 2002; 184:5912 - 5925
   PubMed Web of Science ®Google Scholar
• Murray SR, Bermudes D, de Felipe KS, Low KB. Extragenic suppressors of growth defects in msbB Salmonella. J Bacteriol 2001; 183:5554 - 5561
   PubMed Web of Science ®Google Scholar
• Nikaido H. Multidrug resistance in bacteria. Annu Rev Biochem 2009; 78:119 - 146
   PubMed Web of Science ®Google Scholar
• Lin WJ, Yeh WC. Implication of Toll-like receptor and tumor necrosis factor alpha signaling in septic shock. Shock 2005; 24:206 - 209
   PubMed Web of Science ®Google Scholar
• Liang B, Gardner D, Griswold D, Song X-yR. Protection against Lipopolysaccharide-induced death by an anti-Interleukin-6 monoclonal Antibody. Am J Immunol 2007; 3:4 - 9
   Google Scholar
• Hack CE, De Groot ER, Felt-Bersma RJ, Nuijens JH, Strack Van Schijndel RJ, Eerenberg-Belmer AJ, et al. Increased plasma levels of interleukin-6 in sepsis. Blood 1989; 74:1704 - 1710
   PubMed Web of Science ®Google Scholar
• Jia LJ, Hua ZC. Development of bacterial vectors for tumor-targeted gene therapy. Methods Mol Biol 2009; 542:131 - 154
   PubMedGoogle Scholar
• Soghomonyan SA, Doubrovin M, Pike J, Luo X, Ittensohn M, Runyan JD, et al. Positron emission tomography (PET) imaging of tumor-localized Salmonella expressing HSV1-TK. Cancer Gene Ther 2005; 12:101 - 108
   PubMed Web of Science ®Google Scholar
• Brader P, Stritzker J, Riedl CC, Zanzonico P, Cai S, Burnazi EM, et al. Escherichia coli Nissle 1917 facilitates tumor detection by positron emission tomography and optical imaging. Clin Cancer Res 2008; 14:2295 - 2302
   PubMed Web of Science ®Google Scholar
• Loessner H, Bartels S, Endmann A, Westphal-Daniel K, Wolf K, Kochruebe K, et al. Drug-inducible remote control of gene expression by probiotic Escherichia coli Nissle 1917 in intestine, tumor and gall bladder of mice. Microbes Infect 2009; 11:1097 - 1105
   PubMed Web of Science ®Google Scholar
• Murray SR, de Felipe KS, Obuchowski PL, Pike J, Bermudes D, Low KB. Hot spot for a large deletion in the 18- to 19-centisome region confers a multiple phenotype in Salmonella enterica serovar typhimurium strain ATCC 14028. J Bacteriol 2004; 186:8516 - 8523
   PubMed Web of Science ®Google Scholar
• Murray SR, Ernst RK, Bermudes D, Miller SI, Low KB. pmrA(Con) confers pmrHFIJKL-dependent EGTA and polymyxin resistance on msbB Salmonella by decorating lipid A with phosphoethanolamine. J Bacteriol 2007; 189:5161 - 5169
   PubMed Web of Science ®Google Scholar
• Somerville JE Jr, Cassiano L, Darveau RP. Escherichia coli msbB gene as a virulence factor and a therapeutic target. Infect Immun 1999; 67:6583 - 6590
   PubMed Web of Science ®Google Scholar
• Milton DL, O'Toole R, Horstedt P, Wolf-Watz H. Flagellin A is essential for the virulence of Vibrio anguillarum. J Bacteriol 1996; 178:1310 - 1319
   PubMed Web of Science ®Google Scholar